L-Valine, 3-Methyl-N-[[[(1R,2R)-2-(4-penten-1-yl)cyclopropyl]oxy]carbonyl]- CAS: 1026200-27-0
| Product Parameters | |
|---|---|
| Catalog No. | BK90T4 |
| CAS.RN | 1026200-27-0 |
| Molecular Formula | C15H25NO4 |
| Molecular Weight | 283.36 g/mol |
| Purity | NLT 98% |
Product Overview
This product is a well-defined pharmaceutical intermediate, chemically named (S)-3,3-dimethyl-2-((((1R,2R)-2-(pent-4-en-1-yl)cyclopropoxy)carbonyl)amino)butyric acid, with the English name L-Valine, 3-Methyl-N-[[[(1R,2R)-2-(4-penten-1-yl)cyclopropyl]oxy]carbonyl]-. It belongs to the amino acid derivative class of compounds and is widely used in drug molecule construction and synthetic process development. This intermediate is suitable for different stages of drug development, small-scale preparation, pilot-scale amplification, and commercial production. It exhibits good reactivity and structural stability and can be used as a key starting material or synthetic intermediate in the synthetic pathways of innovative drugs such as antitumor and antiviral drugs.
Applications
- Drug molecule construction and synthesis
- Development of antitumor drug intermediates
- Design of synthetic routes for antiviral drugs
- Customized synthesis of pharmaceutical intermediates
- Process optimization and route development
Quality & Supply Capability
English Name: L-Valine, 3-Methyl-N-[[[(1R,2R)-2-(4-penten-1-yl)cyclopropyl]oxy]carbonyl]- Properties: This product is a white to off-white solid with a stable cyclopropoxy structure and amino functional groups. It exhibits good thermal and chemical stability and is suitable for various organic synthesis reaction systems. Storage Recommendations: Store in a sealed, light-protected, and dry place, subject to the specific COA/MSDS. Supply Capabilities: Samples, gram-level, kilogram-level, commercial batches. Packaging Specifications: Aluminum foil bags, fluorinated bottles, cardboard drums, customized packaging. Document Support: COA, MSDS, HPLC, NMR, etc. We provide a full-process supply service from laboratory samples to industrial batch production. We can provide small-scale preparation, pilot-scale amplification, and customized batch production solutions according to customer needs. We also support flexible adjustments based on customer requirements for purity, impurity control, packaging specifications, delivery cycle, and quality documents to ensure that we meet the needs of different stages of R&D and production. We also have a professional technical support team to assist clients in process development, route optimization, and project transformation, ensuring the smooth progress of projects.
Why Choose Bioncan
Focused on pharmaceutical intermediates, with extensive experience in the synthesis of amino acid compounds. Full-scale supply capability, covering sample, gram, kilogram, and commercial-scale production. Provides complete quality control documentation, including COA, MSDS, HPLC, NMR, etc. Supports customized needs, providing synthesis and packaging design according to specific customer requirements. Supports process optimization and scale-up technologies to help customers achieve efficient transformation and industrialization.
Intermediates of Grazoprevir (potassium salt)
| Catalog No. | Product Name | CAS |
|---|---|---|
| BA52GN | Grazoprevir (potassium salt) API | 1206524-86-8 |
| BK8Q5G | (1R,2S)-1-aMino-N-(cyclopropylsulfonyl)-2-vinylcyclopropanecarboxaMide 4-Methylbenzenesulfonate | 1028252-16-5 |
| BK6N2V | L-Proline, 4-[(3-chloro-7-methoxy-2-quinoxalinyl)oxy]-, methyl ester, (hydrochloride)(1:1),(4R)- | 1361028-94-5 |
| BK90T4 | L-Valine, 3-Methyl-N-[[[(1R,2R)-2-(4-penten-1-yl)cyclopropyl]oxy]carbonyl]- | 1026200-27-0 |
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
Online Consulting
For quotation, inventory, samples, COA, MSDS, or custom synthesis support for CAS 1026200-27-0, please submit your requirements. We will respond according to purity, quantity, delivery timeline, and documentation needs.